Additional file 6 of Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutations
posted on 2021-03-25, 08:38authored byJ. Pei, M. Schuldt, E. Nagyova, Z. Gu, S. el Bouhaddani, L. Yiangou, M. Jansen, J. J. A. Calis, L. M. Dorsch, C. Snijders Blok, N. A. M. van den Dungen, N. Lansu, B. J. Boukens, I. R. Efimov, M. Michels, M. C. Verhaar, R. de Weger, A. Vink, F. G. van Steenbeek, A. F. Baas, R. P. Davis, H. W. Uh, D. W. D. Kuster, C. Cheng, M. Mokry, J. van der Velden, F. W. Asselbergs, M. Harakalova
Additional file 6: Figure S6 Principal component analysis (PCA) plot showing the clustering between control samples and HCM with different truncating mutations in the MYBPC3 gene
Funding
The Netherlands Foundation for Cardiovascular Excellence NWO VENI grant NWO VIDI grant ZonMW-NWO VICI grant Erasmus MC fellowship grant RM fellowship grant of the UMC Utrecht Wilhelmina Children’s Hospital research funding Netherlands Cardiovascular Research Initiative: An initiative with the support of the Dutch Heart Foundation UCL Hospitals NIHR Biomedical Research Centre H2020 European Research Council